Subsense raised $27 million in 2025 to develop "Neural Dust" for Brain-Computer Interfaces (BCIs), a technology moving towards human trials. This private funding indicates significant investor interest in non-invasive neural recording, potentially disrupting the BCI market. Investors should monitor Subsense for future funding rounds or IPOs as this technology advances.